Journal article
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high‐risk cytogenetics: A meta‐analysis of randomized controlled trials
Abstract
BACKGROUND: Despite routine evaluation of cytogenetics in myeloma, little is known regarding the impact of high-dose therapy (HDT) consolidation on overall survival (OS) or progression-free survival (PFS) in patients who have high-risk cytogenetics. The authors performed a meta-analysis of randomized controlled trials (RCTs) to assess the heterogeneity of HDT efficacy according to cytogenetic risk.
METHODS: All RCTs in patients who had newly …
Authors
Chakraborty R; Siddiqi R; Willson G; Gupta S; Asghar N; Husnain M; Aljama MA; Behera TR; Anwer F; Perrot A
Journal
Cancer, Vol. 128, No. 12, pp. 2288–2297
Publisher
Wiley
Publication Date
June 15, 2022
DOI
10.1002/cncr.34211
ISSN
1097-0142